术中自主神经阻滞不同局麻药组合在腹腔镜袖状胃切除术中的随机对照试验
该随机对照试验将160例接受腹腔镜袖状胃切除术的患者随机分入布比卡因+可乐定、布比卡因+地塞米松、布比卡因+地塞米松+琥珀酰明胶三组进行术中自主神经阻滞,评估术后疼痛、恶心呕吐及额外镇痛需求。结果显示三组间低疼痛水平、PONV及镇痛药消耗无统计学差异,均无并发症报告;三组阿片类药物消耗均低于既往仅用0.5%布比卡因的研究,B+D+G组36小时疼痛水平最低且「完美结果」患者比例最高。
要点
- 三种局麻药组合行术中自主神经阻滞在LSG中均安全有效,组间无统计学差异。
- B+D+G组36小时疼痛水平最低、「完美结果」比例最高,但临床意义尚待确定。
- 所有组合的阿片类药物消耗均低于既往仅用0.5%布比卡因的研究。
核心结论
- 术中自主神经阻滞使用不同局麻药组合在LSG患者中安全有效,组间无统计学显著性差异。
- B+D+G组达到最低的36小时疼痛水平和最高的「完美结果」百分比,但临床相关性尚不确定。
- 阿片类药物使用的逐步减少凸显ANB在提高患者安全方面的作用。
研究设计与样本
- 随机临床试验(RCT),纳入160例接受腹腔镜袖状胃切除术(LSG)的患者,随机分入三组。
- 三组分别为布比卡因+可乐定(B+C)、布比卡因+地塞米松(B+D)、布比卡因+地塞米松+琥珀酰明胶(B+D+G)。
- 在术后1、8、24和36小时评估疼痛水平、PONV及额外镇痛药需求。
- 试验方案在ClinicalTrials.gov注册,标识符NCT06137924。
主要发现
- 三组在低疼痛水平、PONV及镇痛药消耗方面均无统计学差异。
- 未报告并发症。
- 三组阿片类药物消耗均低于既往仅使用0.5%布比卡因的索引研究。
- 疼痛水平在24小时达峰,36小时显著下降,尤其在B+D+G组。
- B+D+G组达到最高比例的「完美结果」患者,即无疼痛、无PONV且无需额外镇痛药。
临床怎么用
- 研究结果可能为加速康复外科(ERAS)方案的调整提供参考。
- 支持将术中自主神经阻滞整合入临床实践以改善LSG患者术后结局。
局限性
- B+D+G组最低36小时疼痛水平和最高「完美结果」比例的临床相关性尚待确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advances in minimally invasive techniques, enhanced recovery protocols, and regional pain management have improved postoperative outcomes. However, visceral pain and postoperative nausea and vomiting (PONV) remain challenging, particularly after laparoscopic sleeve gastrectomy (LSG) and other minimally invasive procedures. Intraoperative autonomic neural blockade (ANB) has demonstrated efficacy in addressing these issues, with the duration of the effect its most important limitation. METHODS: This randomized clinical trial (RCT) evaluated the effectiveness of three anesthetic combinations used during ANB for LSG. The combinations were Bupivacaine + Clonidine (B + C), Bupivacaine + Dexamethasone (B + D), and Bupivacaine + Dexamethasone + Gelofusine (B + D + G). 160 patients were randomly assigned to one of the three groups. Pain levels, PONV, and the need for additional analgesics were assessed at 1, 8, 24, and 36 h postoperatively. RESULTS: There was no statistical difference among the groups with low pain levels, PONV, and analgesic consumption across all anesthetic combinations. No complications were reported. Opioid consumption was lower in all three combinations than in our index study using only 0.5% bupivacaine. Pain levels peaked at 24 h and decreased significantly by 36 h, especially in the B + D + G group. The B + D + G group achieved the highest percentage of "perfect result" patients, with no pain, no PONV, and no need for additional analgesics. CONCLUSIONS: This study demonstrates the safety and efficacy of intraoperative ANB using different anesthetic combinations in LSG patients without statistical significance among the groups. The B + D + G group achieved the lowest 36-h pain levels and the highest percentage of "perfect results," although the clinical relevance is tentative. The progressive reduction in opioid use highlights ANB's role in improving patient safety. The findings may inform adjustments to enhanced recovery after surgery (ERAS) protocols and support integrating ANB into clinical practice to improve postoperative outcomes in LSG patients. TRIAL REGISTRATION: The protocol was registered in ClinicalTrials.gov under the identifier NCT06137924.
引用
- Daes J, Pantoja R, Luque E, et al. Intraoperative autonomic neural blockade: comparison between different local anesthetics combinations: a randomized clinical trial. Surg Endosc. 2025. PMID: 40032662. doi:10.1007/s00464-025-11637-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。